Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features
Authors
Keywords
Sequence analysis, HIV-1, Machine learning algorithms, Sequence databases, Amino acid sequence analysis, Algorithms, Amino acid analysis, Cysteine
Journal
PLoS Computational Biology
Volume 15, Issue 4, Pages e1006952
Publisher
Public Library of Science (PLoS)
Online
2019-04-02
DOI
10.1371/journal.pcbi.1006952
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exploiting glycan topography for computational design of Env glycoprotein antigenicity
- (2018) Wen-Han Yu et al. PLoS Computational Biology
- Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials
- (2018) Michal Juraska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120
- (2017) Allan C. deCamp et al. PLoS One
- Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction
- (2017) Ema T. Crooks et al. VIROLOGY
- Prediction of HIV-1 sensitivity to broadly neutralizing antibodies shows a trend towards resistance over time
- (2017) Anna Hake et al. PLoS Computational Biology
- Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial
- (2017) Kenneth H. Mayer et al. PLOS MEDICINE
- Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
- (2016) Dennis R. Burton et al. Annual Review of Immunology
- Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
- (2016) Guillaume B.E. Stewart-Jones et al. CELL
- Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
- (2016) Jinghe Huang et al. IMMUNITY
- Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies
- (2016) Hannah M. Cheeseman et al. JOURNAL OF VIROLOGY
- Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy
- (2016) Marina Caskey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
- (2016) Katharine J. Bar et al. NEW ENGLAND JOURNAL OF MEDICINE
- A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial
- (2016) T. Hertz et al. VACCINE
- Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization
- (2016) Cecilia Rademeyer et al. PLoS Pathogens
- Broadly Neutralizing Antibodies for HIV Eradication
- (2016) Kathryn E. Stephenson et al. Current HIV/AIDS Reports
- Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity
- (2016) Todd Bradley et al. EBioMedicine
- Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
- (2015) J. E. Ledgerwood et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring
- (2015) Maya L. Petersen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- HIV-1 Fitness Cost Associated with Escape from the VRC01 Class of CD4 Binding Site Neutralizing Antibodies
- (2015) Rebecca M. Lynch et al. JOURNAL OF VIROLOGY
- Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
- (2015) Daniel E. Neafsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
- (2015) Hyejin Yoon et al. NUCLEIC ACIDS RESEARCH
- Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
- (2015) Rebecca M. Lynch et al. Science Translational Medicine
- Computationally efficient confidence intervals for cross-validated area under the ROC curve estimates
- (2015) Erin LeDell et al. Electronic Journal of Statistics
- Dose–response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies
- (2015) Nicholas E. Webb et al. Nature Communications
- HIV broadly neutralizing antibody targets
- (2015) Constantinos Kurt Wibmer et al. Current Opinion in HIV and AIDS
- Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial
- (2015) Paul T. Edlefsen et al. PLoS Computational Biology
- Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site
- (2015) Ema T. Crooks et al. PLoS Pathogens
- Mortality prediction in intensive care units with the Super ICU Learner Algorithm (SICULA): a population-based study
- (2015) Romain Pirracchio et al. Lancet Respiratory Medicine
- Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method
- (2014) Mark C Evans et al. BMC BIOINFORMATICS
- Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to human immunodeficiency virus vaccine efficacy trials
- (2014) Peter B. Gilbert et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS
- NEP: web server for epitope prediction based on antibody neutralization of viral strains with diverse sequences
- (2014) Gwo-Yu Chuang et al. NUCLEIC ACIDS RESEARCH
- Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site
- (2014) Piraporn Utachee et al. Retrovirology
- Mark-Specific Hazard Ratio Model with Multivariate Continuous Marks: An Application to Vaccine Efficacy
- (2013) M. Juraska et al. BIOMETRICS
- Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies
- (2013) Tongqing Zhou et al. IMMUNITY
- Residue-Level Prediction of HIV-1 Antibody Epitopes Based on Neutralization of Diverse Viral Strains
- (2013) G.-Y. Chuang et al. JOURNAL OF VIROLOGY
- Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
- (2013) Masashi Shingai et al. NATURE
- Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
- (2013) Dan H. Barouch et al. NATURE
- Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data
- (2013) Andrew L. Ferguson et al. PLoS One
- Antibodies in HIV-1 Vaccine Development and Therapy
- (2013) F. Klein et al. SCIENCE
- Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes
- (2013) Constantinos Kurt Wibmer et al. PLoS Pathogens
- A Single Residue within the V5 Region of HIV-1 Envelope Facilitates Viral Escape from the Broadly Neutralizing Monoclonal Antibody VRC01
- (2012) Dongxing Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sequences in Glycoprotein gp41, the CD4 Binding Site, and the V2 Domain Regulate Sensitivity and Resistance of HIV-1 to Broadly Neutralizing Antibodies
- (2012) S. M. O'Rourke et al. JOURNAL OF VIROLOGY
- A Combination of Broadly Neutralizing HIV-1 Monoclonal Antibodies Targeting Distinct Epitopes Effectively Neutralizes Variants Found in Early Infection
- (2012) L. Goo et al. JOURNAL OF VIROLOGY
- Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
- (2012) Morgane Rolland et al. NATURE
- HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
- (2012) Florian Klein et al. NATURE
- Association of Enhanced HIV-1 Neutralization by a Single Y681H Substitution in gp41 with Increased gp120-CD4 Interaction and Macrophage Infectivity
- (2012) Rajesh Ringe et al. PLoS One
- Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model
- (2012) Milena Veselinovic et al. VIROLOGY
- Genetic and Neutralization Sensitivity of Diverse HIV-1envClones from Chronically Infected Patients in China
- (2011) Hong Shang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells
- (2011) Christopher A. Todd et al. JOURNAL OF IMMUNOLOGICAL METHODS
- An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum
- (2011) G. Ferrari et al. JOURNAL OF VIROLOGY
- Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
- (2011) Y. Li et al. JOURNAL OF VIROLOGY
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
- (2011) Jason S. McLellan et al. NATURE
- Broad neutralization coverage of HIV by multiple highly potent antibodies
- (2011) Laura M. Walker et al. NATURE
- Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
- (2011) Morgane Rolland et al. NATURE MEDICINE
- DIVEIN: a web server to analyze phylogenies, sequence divergence, diversity, and informative sites
- (2010) Wenjie Deng et al. BIOTECHNIQUES
- Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV‐1 gp120 Vaccine
- (2010) Peter Gilbert et al. JOURNAL OF INFECTIOUS DISEASES
- A series of PDB related databases for everyday needs
- (2010) R. P. Joosten et al. NUCLEIC ACIDS RESEARCH
- Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
- (2010) T. Zhou et al. SCIENCE
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
- (2010) X. Wu et al. SCIENCE
- Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
- (2010) S. Gnanakaran et al. PLoS Computational Biology
- Novel Ring Structure in the gp41 Trimer of Human Immunodeficiency Virus Type 1 That Modulates Sensitivity and Resistance to Broadly Neutralizing Antibodies
- (2009) S. M. O'Rourke et al. JOURNAL OF VIROLOGY
- Enhancing Exposure of HIV-1 Neutralization Epitopes through Mutations in gp41
- (2007) Catherine A Blish et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now